Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David Astling"'
Autor:
Feyza Yilmaz, Megan Null, David Astling, Hung-Chun Yu, Joanne Cole, Stephanie A. Santorico, Benedikt Hallgrimsson, Mange Manyama, Richard A. Spritz, Audrey E. Hendricks, Tamim H. Shaikh
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-11 (2021)
Abstract Background Copy number variations (CNVs) account for a substantial proportion of inter-individual genomic variation. However, a majority of genomic variation studies have focused on single-nucleotide variations (SNVs), with limited genome-wi
Externí odkaz:
https://doaj.org/article/b7f1d471c8d341818264cedc031533af
Autor:
Megan Null, Feyza Yilmaz, David Astling, Hung-Chun Yu, Joanne B. Cole, Benedikt Hallgrímsson, Stephanie A. Santorico, Richard A. Spritz, Tamim H. Shaikh, Audrey E. Hendricks
Publikováno v:
HGG Advances, Vol 3, Iss 1, Pp 100082- (2022)
Similarity in facial characteristics between relatives suggests a strong genetic component underlies facial variation. While there have been numerous studies of the genetics of facial abnormalities and, more recently, single nucleotide polymorphism (
Externí odkaz:
https://doaj.org/article/33d2bde0be194f3296718f47b89ac036
Autor:
Stephen A. Williams, Rachel Ostroff, Michael A. Hinterberg, Josef Coresh, Christie M. Ballantyne, Kunihiro Matsushita, Christian E. Mueller, Joan Walter, Christian Jonasson, Rury R. Holman, Svati H. Shah, Naveed Sattar, Roy Taylor, Michael E. Lean, Shintaro Kato, Hiroaki Shimokawa, Yasuhiko Sakata, Kotaro Nochioka, Chirag R. Parikh, Steven G. Coca, Torbjørn Omland, Jessica Chadwick, David Astling, Yolanda Hagar, Natasha Kureshi, Kelsey Loupy, Clare Paterson, Jeremy Primus, Missy Simpson, Nelson P. Trujillo, Peter Ganz
Publikováno v:
Yearbook of Paediatric Endocrinology.
A reliable, individualized, and dynamic surrogate of cardiovascular risk, synoptic for key biologic mechanisms, could shorten the path for drug development, enhance drug cost-effectiveness and improve patient outcomes. We used highly multiplexed prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af50c296b3f5e925f23f621075af8a4
https://doi.org/10.1530/ey.19.14.9
https://doi.org/10.1530/ey.19.14.9
Autor:
Megan Null, Feyza Yilmaz, David Astling, Hung-Chun Yu, Joanne B. Cole, Benedikt Hallgrímsson, Stephanie A. Santorico, Richard A. Spritz, Tamim H. Shaikh, Audrey E. Hendricks
Publikováno v:
Human Genetics and Genomics Advances
HGG Advances, Vol 3, Iss 1, Pp 100082-(2022)
HGG Advances, Vol 3, Iss 1, Pp 100082-(2022)
Similarity in facial characteristics between relatives suggests a strong genetic component underlies facial variation. While there have been numerous studies of the genetics of facial abnormalities and, more recently, single nucleotide polymorphism (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a9b02ae15496e406c1419508056a69
http://europepmc.org/articles/PMC8756499
http://europepmc.org/articles/PMC8756499
Autor:
Stephen A Williams, Rachel Ostroff, Michael Hinterberg, Josef Coresh, Christie M Ballantyne, Kunihiro Matsushita, Christian Mueller, Joan E Walter, Christian Jonasson, Rury H Holman, Svati H Shah, Naveed Sattar, Roy Taylor, Michael Lean, Shintaro Kato, Hiroaki Shimokawa, Yasuhito Sakata, Kotaro Nochioka, Chirag Parikh, Steven Coca, Torbjoern Omland, Jessica Chadwick, David Astling, Yolanda Hagar, Natasha Kurieski, Jeremy Primus, Missy Simpson, Nelson P Trujillo, Peter Ganz
Publikováno v:
Circulation. 144
Introduction: The critical path for novel treatment and prevention strategies, both pharmacological and non-pharmacological, requires clinical outcomes trials, which are slow, expensive and retard patient access to successful therapies. For marketed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91008c6dee80b4bb0a2343ba36cb2d76
https://doi.org/10.1161/circ.144.suppl_1.11537
https://doi.org/10.1161/circ.144.suppl_1.11537
Autor:
Markus C. Kowarik, David Astling, Gildas Lepennetier, Alanna Ritchie, Bernhard Hemmer, Gregory P. Owens, Jeffrey L. Bennett
Background: B cells are postulated to play multiple roles in the pathogenesis of multiple sclerosis (MS) including pathogenic antibody production, antigen-presentation and pro-inflammatory cytokine secretion. Natalizumab and fingolimod are effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::140b0378005478a320e9e9c17449129b
https://doi.org/10.21203/rs.3.rs-23388/v1
https://doi.org/10.21203/rs.3.rs-23388/v1
